|
ATP13A3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.98686999999254E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.832300E-04 |
| Normal-vs-Stage2 |
1.086650E-01 |
| Normal-vs-Stage3 |
4.845300E-04 |
| Normal-vs-Stage4 |
2.172800E-04 |
| Stage1-vs-Stage2 |
3.769200E-01 |
| Stage1-vs-Stage3 |
3.965600E-01 |
| Stage1-vs-Stage4 |
3.936800E-01 |
| Stage2-vs-Stage3 |
1.489850E-01 |
| Stage2-vs-Stage4 |
1.305000E-01 |
| Stage3-vs-Stage4 |
9.994800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.52540000000401E-05 |
| Normal-vs-AfricanAmerican |
4.506000E-02 |
| Normal-vs-Asian |
9.467700E-02 |
| Caucasian-vs-AfricanAmerican |
5.968800E-01 |
| Caucasian-vs-Asian |
1.615010E-01 |
| AfricanAmerican-vs-Asian |
1.260550E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.430400E-04 |
| Normal-vs-Female |
1.98080000002321E-06 |
| Male-vs-Female |
3.944400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.009700E-02 |
| Normal-vs-Age(41-60Yrs) |
2.3753999999987E-05 |
| Normal-vs-Age(61-80Yrs) |
2.806200E-04 |
| Normal-vs-Age(81-100Yrs) |
9.821000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.632400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.695400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.322850E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.053400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.127900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.321900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.230260E-02 |
| Normal-vs-Grade 2 |
3.52520000002077E-06 |
| Normal-vs-Grade 3 |
4.041100E-03 |
| Normal-vs-Grade 4 |
2.139700E-02 |
| Grade 1-vs-Grade 2 |
9.954600E-01 |
| Grade 1-vs-Grade 3 |
3.114600E-01 |
| Grade 1-vs-Grade 4 |
4.727400E-01 |
| Grade 2-vs-Grade 3 |
2.639700E-02 |
| Grade 2-vs-Grade 4 |
1.445990E-01 |
| Grade 3-vs-Grade 4 |
8.875400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.593100E-04 |
| Normal-vs-ccB subtype |
1.63787999999387E-05 |
| ccA subtype-vs-ccB subtype |
1.537030E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.225450E-04 |
| Normal-vs-N1 |
9.673900E-02 |
| N0-vs-N1 |
5.817600E-01 |
|
|
